infliximab

Known as: INF, Antibody cA2, Monoclonal, MAb cA2 
A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
1874 Sleep duration and quality are associated with immune markers, self-rated health, and mortality in a large cohort (NHANES… (More)
Is this relevant?
Review
2017
Review
2017
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League Against Rheumatism (EULAR) RA management… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti-tumor necrosis factor… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Treatment with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, can result in the… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND We did a randomised controlled trial to assess the benefit of maintenance infliximab therapy in patients with active… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
UNLABELLED BACKGROUND Treatment options for patients with ankylosing spondylitis are few. We aimed to assess the effectiveness of… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Infliximab is a humanized antibody against tumor necrosis factor alpha (TNF-alpha) that is used in the treatment of… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Neutralization of tumor necrosis factor a (TNF-alpha) for three to six months reduces the symptoms and signs of… (More)
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?